#AACR26: KRAS drugmakers take another, better swing at lung cancer
#AACR26：KRAS药企对肺癌再度出击，表现更胜一筹

SAN DIEGO — In early cuts of data, the next iteration of KRAS drugs for lung cancer appears to bear more promise than the first.
圣地亚哥——在早期数据切片中，用于肺癌的下一代KRAS药物似乎比第一代更有前景。